Task: Answer the multiple choice question.
Question: Which compound exhibits a 14.807% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a.) Cc1nn2cc(-c3ncc(C(F)(F)F)cc3Cl)cnc2c1Br
b.) COc1ccc(/C=N/NC(=O)CSc2ccccn2)cc1OC
c.) CS(=O)(=O)N1CCC(Oc2ccccc2C(=O)NC2CCOC2)CC1
d.) CCOC(=O)c1[nH]c(C)c(C(=O)OC(C)C(=O)Nc2ncc(Cl)cc2Cl)c1C
e.) CN(C(=O)c1ccncc1)C1CC(C)(C)N(O)C(C)(C)C1
Answer: a. Cc1nn2cc(-c3ncc(C(F)(F)F)cc3Cl)cnc2c1Br
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nn2cc(-c3ncc(C(F)(F)F)cc3Cl)cnc2c1Br
Cc1nn2cc(-c3ncc(C(F)(F)F)cc3Cl)cnc2c1Br
3-bromo-6-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]-2-methylpyrazolo[1,5-a]pyrimidine